High doses of blood thinner appear harmful I pasted

New Post Public Reply Private Reply Replies (0) Message Board
Enjay
824
High doses of blood thinner appear harmful

I pasted excerpts below from an article in The Philadelphia Inquirer. Hopefully this sort of experimentation won't be necessary after Leronlimab is approved.

https://www.inquirer.com/health/coronavirus/c...10104.html

Troy Randle’s COVID-19 symptoms were difficult yet bearable. After recovering from fever, cough, and headache that started in late March, he was cleared to return to work as a cardiologist in the Virtua Health network in South Jersey.

But after Randle was back on the job for two days in mid-April, his head began to ache again, and it was different. He felt as if it were being squeezed in a vise.

An MRI revealed that a blood clot had blocked an artery in Randle’s brain. He was suffering a stroke.

Physicians worldwide were starting to report the same thing in some of the sickest patients with COVID, as well as a mysterious increase in smaller blood clots elsewhere in the body. In the lungs, the liver, the kidneys — even the toes, as in those purplish “COVID toes” depicted in many a social-media feed months ago. Many hospitals began treating COVID patients with high doses of blood thinners as a preventive measure.

Three international studies of whether that was the right call, including one overseen by researchers at the University of Pittsburgh, are starting to yield results. For patients in intensive care, to the surprise of some physicians involved in the trials, the answer seems to be no.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Halozyme's Upcoming Investment Presentation at Healthcare Conference

Updated Category News Views 280

Halozyme's Participation in Major Healthcare Conference Halozyme Therapeutics, Inc. (NASDAQ: HALO) is set to showcase its advancements at an important healthcare conference. Dr. Helen Torley, the president and CEO, will present and engage in investor meetings, highlighting the company's innovative approaches in the biopharmaceutical sector. Details of the Presentation The...

Continue Reading
Emerging Markets Surge Ahead with Historic Bond Sales Strategy

Updated Category News Views 241

Emerging Markets Adjust with Record Bond Sales Amid economic uncertainty, borrowers in developing regions are intensifying their efforts to navigate potential market turbulence, particularly due to significant fluctuations influenced by US economic conditions. Authorities and businesses have proactively begun securing funds through bond sales, reflecting a strategic move...

Continue Reading
Multi Ways Holdings Reflects on Fiscal Year 2024 Performance

Updated Category News Views 167

Multi Ways Holdings Limited Reports on Financial Results Multi Ways Holdings Limited (NYSE American: MWG), a prominent provider of heavy construction equipment, has recently shared its financial outcomes for the fiscal year 2024. With a focus on innovation and customer satisfaction in Singapore and neighboring regions, the company continues to adapt to the dynamic market...

Continue Reading
Neurocrine Adjusts Course Following Luvadaxistat Study Setback

Updated Category News Views 117

Neurocrine Biosciences Shifts Strategy After Luvadaxistat Trial Neurocrine Biosciences Inc. (NASDAQ: NBIX) has made revisions to its strategic approach following the outcomes of the ERUDITE phase two clinical trial involving luvadaxistat (NBI-1065844). This investigational treatment aimed at addressing cognitive impairment in schizophrenia did not achieve its primary...

Continue Reading
Rinnai America Leads Coalition Against DOE Water Heater Rule

Updated Category News Views 294

Rinnai America Takes Action Against DOE Regulations Rinnai America Corporation, a prominent manufacturer of noncondensing tankless water heaters, has joined forces with 21 state attorneys general and various business groups to challenge the recent final rule issued by the U.S. Department of Energy (DOE) concerning consumer tankless water heaters. This action follows a...

Continue Reading